Spots Global Cancer Trial Database for flumatinib mesylate tablet 600 mg qd
Every month we try and update this database with for flumatinib mesylate tablet 600 mg qd cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Phase II Study to Evaluate the Efficacy and the Safety of Flumatinib in CML-AP or CML-BP Patients | NCT02511340 | Chronic Myeloge... | Flumatinib mesy... | 18 Years - 75 Years | Jiangsu Hansoh Pharmaceutical Co., Ltd. | |
| A Phase II Study to Evaluate the Efficacy and the Safety of Flumatinib in CML-AP or CML-BP Patients | NCT02511340 | Chronic Myeloge... | Flumatinib mesy... | 18 Years - 75 Years | Jiangsu Hansoh Pharmaceutical Co., Ltd. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
